Bone capital refers to our ability to preserve our bone mass. This bone mass decreases with age during the aging process or even in the event of immobilization: this is called osteoporosis, characterized both by a decrease in bone density and by a modification of its architecture. As the bone is more fragile, the risk of fractures increases. Osteopenia is the early form of osteoporosis and usually begins around the age of 35.
This disease, disabling due to the increased risk of fractures it causes, was responsible for the hospitalization of 177,000 people in 2013 following fractures (Source: Ameli). These hospitalizations concern 3 women for 1 man and the most frequent osteoporotic fractures are those of the femur, vertebrae and wrist.
Bone and nutraceutical capital:
In nutraceuticals, the preservation of bone capital is based on the following active ingredients:
• Specific collagen hydrolysates clinically studied to improve bone mineral density
• Vitamin K, which contributes to normal bones
• Vitamin D, which stimulates the absorption of calcium by the intestine
• Calcium, an essential component of bone, which in case of deficiency is responsible for osteoporosis
• Silica or silicon traditionally used to promote bone remineralization
Showing all 4 results
Showing all 4 results